PER percheron therapeutics limited
Add to My Watchlist 0.00% ! 1.0¢

Ann: Notices received under s203D and s249D of Corporations Act, page-138

  1. 1MRX
    510 Posts.
    lightbulb Created with Sketch. 31
    clock Created with Sketch.
    11/01/25
    22:42
    Post #: 77365751
    Reassuring if it’s not the companies fault but what if it was setup for failure by the company trial design by having the drug dose being done off site and not at a hospital by a medical professional.
    PER Price at posting: 0.9¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Pilbara Exploration Identifies High-Grade Gold and Antimony Targets
right-arrow Created with Sketch.
NEWS High-grade monazite-rich mineral sands discovery confirmed at Minta Est
right-arrow Created with Sketch.
NEWS Trident Infill Drilling Results Confirm Resource as Development Gets Underway
right-arrow Created with Sketch.
NEWS Many are concerned about global falling birthrates. This diverse stock has solutions
right-arrow Created with Sketch.
NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.